NCT02568553 2025-11-26Lenalidomide and Blinatumomab for the Treatment of Relapsed Non-Hodgkin LymphomaNational Cancer Institute (NCI)Phase 1 Completed35 enrolled
NCT02458014 2025-09-23Blinatumomab in Treating Patients With B-cell Acute Lymphoblastic Leukemia With Minimal Residual DiseaseM.D. Anderson Cancer CenterPhase 2 Completed36 enrolled